Nationwide Building Society Publication of Suppl.Prospcts (9881S)

TIDMNBS TIDM34VG

RNS Number : 9881S

Nationwide Building Society

19 November 2021

Publication of Supplement

The following supplement to prospectuses has been approved by the Financial Conduct Authority and is available for viewing:

Nationwide Building Society *

Supplement dated 19 November 2021 to (i) the Base Prospectus dated 29 October 2021, prepared in connection with the U.S.$25,000,000,000 European Note Programme established by Nationwide Building Society; (ii) the Base Prospectus dated 12 February 2021 (as supplemented on 24 May 2021), prepared in connection with the EUR45,000,000,000 Global Covered Bond Programme; and (iii) the Base Prospectus dated 29 June 2021, prepared in connection with the U.S.$20,000,000,000 Senior Preferred, Senior Non-Preferred and Subordinated Medium-Term Note Programme, each established by Nationwide Building Society.

To view the full document, please paste the URL into the address bar of your browser.

Supplement dated 19 November 2021 in respect of the U.S.$25,000,000,000 European Note Programme, the EUR45,000,000,000 Global Covered Bond Programme and the U.S.$20,000,000,000 Senior Preferred, Senior Non-Preferred and Subordinated Medium-Term Note Programme

http://www.rns-pdf.londonstockexchange.com/rns/9881S_1-2021-11-19.pdf

A copy of the Supplement will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

For further information, please contact

Nationwide Building Society

Charlie Wood

Head of Financial Risk Strategy & Investor Relations

   Telephone:       [phone] 
   Email:              [e-mail] 

* LEI: 549300XFX12G42QIKN82

DISCLAIMER - INTENDED ADDRESSEES

UK MiFIR professionals/ECPs only/No UK PRIIPs KID

EU MiFID II professionals/ECPs only/No PRIIPs KID

Please note that the information contained in the relevant Base Prospectus (as supplemented by the Supplement) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the relevant Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the relevant Base Prospectus is not addressed. Prior to relying on the information contained in the relevant Base Prospectus you must ascertain from such Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPFLFILLALALIL

(END) Dow Jones Newswires

November 19, 2021 06:13 ET (11:13 GMT)